Blue Jet Healthcare experienced a notable increase in its stock price, rising by up to 10% after announcing a 60% sequential growth in net profit for the March quarter, which reached ₹64.34 crore. This profit increase is significant compared to the previous quarter's profit of ₹40.16 crore, although it reflects a 41% decline from ₹110 crore in the same quarter of the previous financial year. The company reported a 31% year-on-year drop in revenue from operations, totaling ₹235 crore, but noted a 14% increase from ₹206 crore in the December quarter. In addition to the profit announcement, Blue Jet Healthcare's board has proposed a final dividend of ₹1.2 per equity share for FY26, subject to shareholders' approval. Furthermore, the board approved a plan to raise up to ₹1,000 crore through methods such as qualified institutional placement and private placement, pending regulatory and shareholder approvals. An extraordinary general meeting is set for June 17, 2026, to seek approval for this fundraising initiative.